Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1971 1
1974 1
1975 2
1977 2
1979 1
1980 1
1981 3
1983 3
1984 1
1985 6
1986 5
1987 1
1989 6
1990 7
1991 6
1992 4
1993 5
1994 8
1995 9
1996 3
1997 14
1998 13
1999 14
2000 14
2001 17
2002 19
2003 19
2004 18
2005 14
2006 9
2007 12
2008 14
2009 7
2010 9
2011 9
2012 13
2013 12
2014 5
2015 6
2016 11
2017 6
2018 7
2019 9
2020 16
2021 10
2022 6
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Results by year

Filters applied: . Clear all
Page 1
Mycobacterium vaccae immunotherapy for treating tuberculosis.
de B, Garner P. de B, et al. Cochrane Database Syst Rev. 2001;(1):CD001166. doi: 10.1002/14651858.CD001166. Cochrane Database Syst Rev. 2001. PMID: 11279709 Updated. Review.
BACKGROUND: Some authorities have advocated Mycobacterium vaccae immunotherapy for treating tuberculosis and other infections caused by mycobacteria. OBJECTIVES: To assess the effects of Mycobacterium vaccae as an adjunct to chemotherapy for treating t …
BACKGROUND: Some authorities have advocated Mycobacterium vaccae immunotherapy for treating tuberculosis and other infections …
Mycobacterium vaccae immunotherapy for treating tuberculosis.
de Bruyn G, Garner P. de Bruyn G, et al. Cochrane Database Syst Rev. 2000;(2):CD001166. doi: 10.1002/14651858.CD001166. Cochrane Database Syst Rev. 2000. PMID: 10796609 Updated. Review.
BACKGROUND: Mycobacterium vaccae has been advocated for immunotherapy in the treatment of tuberculosis and other infections caused by mycobacteria. ...SELECTION CRITERIA: Randomised and quasi-randomised trials of preparations of whole, killed Mycobacterium …
BACKGROUND: Mycobacterium vaccae has been advocated for immunotherapy in the treatment of tuberculosis and other infections ca …
Mycobacterium vaccae immunotherapy for treating tuberculosis.
de Bruyn G, Garner P. de Bruyn G, et al. Cochrane Database Syst Rev. 2003;(1):CD001166. doi: 10.1002/14651858.CD001166. Cochrane Database Syst Rev. 2003. PMID: 12535403 Review.
BACKGROUND: Some authorities have advocated Mycobacterium vaccae immunotherapy for treating tuberculosis and other infections caused by mycobacteria. OBJECTIVES: To assess the effects of Mycobacterium vaccae as an adjunct to chemotherapy for treating t …
BACKGROUND: Some authorities have advocated Mycobacterium vaccae immunotherapy for treating tuberculosis and other infections …
Mycobacterium Vaccae Regulate γδT17 and γδTreg Cells in Mice Asthmatic Lung.
Yao Y, Chen X, Qin C, Huang J, Xu S, Li C. Yao Y, et al. Iran J Immunol. 2022 Sep;19(3):243-254. doi: 10.22034/iji.2022.94460.2311. Iran J Immunol. 2022. PMID: 36190379 Free article.
Background Dysregulation of the balance between different T cell populations is believed to be an important basis for asthma.Objective To observe the changes in gammadeltaT subtypes in transgenic asthmatic mice after aerosol inhalation of Mycobacterium vaccae, and t …
Background Dysregulation of the balance between different T cell populations is believed to be an important basis for asthma.Objective To ob …
Mycobacterium vaccae immunization in rats ameliorates features of age-associated microglia activation in the amygdala and hippocampus.
Sanchez K, Darling JS, Kakkar R, Wu SL, Zentay A, Lowry CA, Fonken LK. Sanchez K, et al. Sci Rep. 2022 Feb 9;12(1):2165. doi: 10.1038/s41598-022-05275-y. Sci Rep. 2022. PMID: 35140249 Free PMC article.
Prior studies indicate that immunization with the immunoregulatory and anti-inflammatory bacterium, Mycobacterium vaccae (M. vaccae), in aged rats limits neuroimmune activation and cognitive impairments. ...Here, we investigated whether M. vaccae immun …
Prior studies indicate that immunization with the immunoregulatory and anti-inflammatory bacterium, Mycobacterium vaccae (M. …
Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
Huang CY, Hsieh WY. Huang CY, et al. Hum Vaccin Immunother. 2017 Sep 2;13(9):1960-1971. doi: 10.1080/21645515.2017.1335374. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28604170 Free PMC article. Review.
The purpose of this study was to perform a meta-analysis investigating the effectiveness of the M. vaccae vaccine. Medline, Cochrane, EMBASE, and Google Scholar were searched until November 5, 2015 using the keywords: tuberculosis, pulmonary TB, therapeutic vaccines, immun …
The purpose of this study was to perform a meta-analysis investigating the effectiveness of the M. vaccae vaccine. Medline, Cochrane, …
Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis.
Yang XY, Chen QF, Cui XH, Yu Y, Li YP. Yang XY, et al. J Infect. 2010 May;60(5):320-30. doi: 10.1016/j.jinf.2010.02.005. Epub 2010 Feb 13. J Infect. 2010. PMID: 20156481 Review.
OBJECTIVE: To evaluate the effectiveness and safety of Mycobacterium vaccae (MV) in prevention of tuberculosis (TB) among high risk people. ...CV (control vaccine) of positive stimulation index (SI) (> or = 3) in lymphocyte proliferation assays (LPA) to Mycoba …
OBJECTIVE: To evaluate the effectiveness and safety of Mycobacterium vaccae (MV) in prevention of tuberculosis (TB) among high …
Mycobacterium vaccae Lysate Induces Anti-Allergic Immune Response In Vitro.
Strygin AV, Nesmiyanov PP, Petrov VI, Tolkachev BE, Morkovin EI, Gutov MV, Strygina AO. Strygin AV, et al. Bull Exp Biol Med. 2020 Dec;170(2):226-229. doi: 10.1007/s10517-020-05039-6. Epub 2020 Dec 3. Bull Exp Biol Med. 2020. PMID: 33270158
Mycobacterium vaccae is a soil saprophyte which exerts anti-allergic properties. ...M. vaccae lysate stimulated IL-10 synthesis in co-cultures and CD86 expression in dendritic cells, being more potent than heat-killed M. vaccae. ...
Mycobacterium vaccae is a soil saprophyte which exerts anti-allergic properties. ...M. vaccae lysate stimulated IL-10 s …
Mycobacterium vaccae immunotherapy.
Pozniak A, Stanford JL, Grange JM. Pozniak A, et al. Lancet. 1991 Dec 14;338(8781):1533-4. doi: 10.1016/0140-6736(91)92360-e. Lancet. 1991. PMID: 1683960 No abstract available.
Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis.
Stanford JL, Rook GA, Bahr GM, Dowlati Y, Ganapati R, Ghazi Saidi K, Lucas S, Ramu G, Torres P, Minh Ly H, et al. Stanford JL, et al. Vaccine. 1990 Dec;8(6):525-30. doi: 10.1016/0264-410x(90)90002-4. Vaccine. 1990. PMID: 2087873 Review.
Improved immunoprophylaxis, and an effective immunotherapy to be used with chemotherapy are urgently required. Intradermal injection of a suspension of killed Mycobacterium vaccae promotes cell-mediated responses to antigens common to all mycobacteria, and switches …
Improved immunoprophylaxis, and an effective immunotherapy to be used with chemotherapy are urgently required. Intradermal injection of a su …
364 results